Replies to post #328883 on Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

I don’t think the company will show profit the next quarter due to the warning about increased R&D. There may even be a reduction in revs due to the Adderall situation that effects both ongoing IR and the ER launch. Also, don’t think we will show net income during Aug or perhaps even the Nov call. I expect share price to increase by end of year with the ER launch & expected rev, which triggers the accounting expense for warrants offsetting expected earned income (meaning higher share price during the period).